Services
 

Overview

MZ Biolabs provides unequaled analytical and testing services for the research community. ​We excel at mass spectrometer method development for drugs, diagnostic markers, metabolites, metabolomics, and proteomics. Mass spec allows us to perform testing on very small samples sizes, ideal for exotics and other small or hard to acquire samples. Our knowledgeable staff can help with planning the experiments and analytical assays for your projects and provide feedback during the testing period.​

Range of Services

We can develop new mass spec methods for your project or provide testing from our menu. We work on most sample formats from tissue culture, and animal samples through to human studies.  We can develop and validate testing to establish new diagnostic tests.

Menu

Our analyte menu is extensive:
  • immunosuppressant monitoring
  • taurine, SDMA, & amino acids​
  • steroid hormones
  • vitamin C, D & B1
  • drug & toxicology/monitoring
  • lipids & fatty acids, short chain through very long chain (seed lipid analysis) 
  • metabolites
  • proteomics & metabolomics
Inquire for new and other analytes as they are too numerous to list

Method development

We develop methods for a variety of analytes, including: small molecule metabolites, new chemical entities and their metabolites, drug monitoring, peptides, and other compounds unavailable on diagnostic menus. We can advise on optimal compounds to test for in metabolic pathways and compound metabolites.


Animal studies support

We support analytical testing for drugs (established or NCEs) and their metabolites, drug monitoring, and metabolic markers. Mass spec analysis allows us to use small sample volumes and retain accuracy for animal studies. We can provide pharmacokinetic and other analysis of the data.

Proteomics & metabolomics

We provide untargeted proteomic and metabolomic analysis, with protein/metabolite identification and relative differential expression analysis (heat mapping). We work on a wide variety of organisms and tissues.​ Our enhanced proteomics work now includes polypeptide sequencing and identification of binding pairs, such as antibody epitopes or TCR/MHC peptides.
​

Collaborations

We are pleased to collaborate on R&D projects for discovery, new diagnostics, companion diagnostic development, or translational development, including to partner on grants or SBIR/STTR applications. For SBIR/STTR grants our interest is in new testing, including companion diagnostics, that can be offered to the medical and/or veterinary markets.


What our customers say:

“I just wanted to let you know that your data was fantastic! It really helped us validate our models. Your sensitivity is excellent.Thank you very much!"
Paul, pharma company executive

"I just wanted to send a note thanking you for your time and responsiveness to our request. We were struggling in finding a solution, but you pulled through for us! 
Sincerest appreciation for your support."
Nicole, Clinical Lab Supervisor